Measles vaccine Market 2028 Type, Application | The Insight Partners

report image

Measles vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type ( Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) ); Application ( Children, Adults )

Report Code: TIPRE00010959 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Measles is a severe and infectious disease triggered by a virus. Early symptoms of the disease are fever, red eyes, runny nose, and cough. Later, red spots and tiny rashes are observed on skin. Measles is spread by a virus belonging to the paramyxovirus family, genus Morbillivirus. The diameter of virus is 120 nm to 250 nm. Measles only occurs in humans and not in animals. The measles virus first infects only the respiratory tract, then spreads throughout the body.


The measles vaccine market is driving due to the increasing number of incidences and prevalence of the disease and continuous efforts of the government and non-government agencies. Moreover, due to powerful regulations and patient safety the measles vaccine market is driving in the forecast period.


The "Measles vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of measles vaccine market with detailed market segmentation by of type and application. The measles vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in measles vaccine market and offers key trends and opportunities in the market.


The measles vaccine market is segmented on the basis of type and application. Based on type, the market is segmented as mumps measles rubella vaccine, live (MMR-II) and mumps measles rubella and varicella virus vaccine (Proquad). On the basis of application, the market is categorized children and adult.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the measles vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The measles vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting measles vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the measles vaccine market in these regions.

Get more information on this report :


The report covers key developments in the measles vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from measles vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for measles vaccine in the global market. Below mentioned is the list of few companies engaged in the measles vaccine market.

The report also includes the profiles of key players in measles vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    - Bavarian Nordic
    - CSL Limited
    - Emergent Biosolutions
    - GlaxoSmithKline plc
    - Johnson and Johnson
    - Merck & Co., Inc.
    - Novartis
    - Pfizer
    - Sanofi-Pasteur
    - Serum Institute of India

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Bavarian Nordic
2. CSL Limited
3. Emergent Biosolutions
4. GlaxoSmithKline plc
5. Johnson and Johnson
6. Merck & Co., Inc.
7. Novartis
8. Pfizer
9. Sanofi-Pasteur
10. Serum Institute of India
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount